Simultaneous Prenatal cfDNA Screening of Aneuploidy, Recessive Single-Gene Conditions, and Fetomaternal Blood Compatibility
FIRSTGENE demonstrated high analytical sensitivity and analytical specificity for each component of the assay. Its capability to generate multiple prenatal screening results from a single blood draw may improve the efficiency and accessibility of prenatal genetic screening.
Authors
- Genevieve Gould
- Anu Priyadharshini Srinivasan (ORCID: https://orcid.org/0000-0002-3251-7069)
- Helen Y. Wan
- Divya Kushnoor
- Juexiao Sherry Wang
- Heather G. LaBreche
- Summer Pierson
- Janani Saikumar (ORCID: https://orcid.org/0000-0002-8930-2472)
- Nafei Xu
- Ravi B. Patel (ORCID: https://orcid.org/0000-0002-8328-746X)
- Ben F. Habermeyer
- Dale Muzzey (ORCID: https://orcid.org/0000-0001-8822-2035)
- Sangita Ganesh (ORCID: https://orcid.org/0009-0009-6312-1815)
- Kyle D. Trettin
- C J Battey
- Nathaniel Friedrich
Institutions
- Myriad (Germany) (DE)
- Myriad Genetics (US)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1093/clinchem/hvag005
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00